Omnicell, Inc. (NASDAQ: OMCL) announces results for its second quarter ended June 30, 2019.
Combination of Automation and Data Analytics Will Enhance Control and Efficiency to Free Up Pharmacists to Support Patient Care
Combination of Technology and Intelligence Will Help Enhance Safety, Control and Efficiency
New Central Distribution Center Incorporates Automation Solutions Designed to Help Enhance Quality and Safety Across Existing and Newly Acquired Facilities
High Quality Design of New easyblist fill2light Supports Safety and Efficiency in Medication Packaging
Omnicell UK Launches Vision for Autonomous Pharmacy at Clinical Pharmacy Congress
Automation of Processes Supports More Cost-effective Sterile Compounding and Improved Workflows in Patient Care Areas
Extension of Partnership Leverages Automation to Support Central Pharmacy Operations and Patient Care Initiatives
Council Member Brandi Gabbard of District 2 to Join Company Leadership for May 1st Dedication Ceremony
Omnicell, Inc. (NASDAQ: OMCL) announces results for its first quarter ended March 31, 2019.
New Solutions Will Help Optimize Workflows and Enhance Patient Safety
Solutions Leverage Automation to Optimize Hospital Workflows, Improve Financial Performance and Enhance Patient Safety
Automation for Sterile Compounding and Patient Care Areas Support Improved Clinical Care
Company to Feature Fully Digitized, Autonomous Pharmacy Vision in Booth #1208
Company to Showcase Advanced Automation to Improve Medication Management
New Solutions to Help Improve Efficiency and Safety in Patient Care Areas and Create More Autonomous Process for In-house Sterile Compounding in Pharmacy